Stocks · Healthcare · Medical - Diagnostics & Research
Personalis, Inc. PSNL
$16.28 +0.68% Close, Oct 2, 2026 · NASDAQ · Market cap $1.74B
Strong trend
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -164.1% from -89.6% a year earlier.
- The diluted share count rose 19.1% in a year.
- Over the past year the stock returned +135.6%, ahead of the S&P 500 by 120.5 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 18%
- Revenue growth, 3-year CAGRBottom 30%
- Revenue growth accelerationTop 12%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 31%
- Gross marginBottom 11%
- Operating marginBottom 26%
- Accruals (lower is better)Bottom 41%
- Interest coverBottom 8%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 47%
- Free-cash-flow yieldBottom 48%
- EBITDA / enterprise valueBottom 48%
- Sales / enterprise valueBottom 18%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 11%
- 6-month returnTop 4%
- 1-year return vs S&P 500Top 9%
- Distance from 52-week highTop 22%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 38%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetBottom 7%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 37%
- Maximum drawdown, 3 yearsTop 29%
- Beta vs S&P 500 (lower is better)Bottom 49%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -24.7% | -13.3% | ↑ |
| Gross margin | 31.4% | 12.7% | ↓ |
| Operating margin | -89.6% | -164.1% | ↓ |
| FCF margin | -61.2% | -144.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -13.3% | -24.7% | ↑ | Bottom 18% |
| Gross margin | 12.7% | 31.4% | ↓ | Bottom 11% |
| Operating margin | -164.1% | -89.6% | ↓ | Bottom 26% |
| Net margin | -153.8% | -113.7% | ↓ | — |
| Free-cash-flow margin | -144.9% | -61.2% | ↓ | — |
| Return on invested capital | -41.8% | — | Bottom 31% | |
| Revenue growth, 3-year CAGR | 2.3% | — | Bottom 30% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 15.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +65.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -536.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -8.10%
- Shareholder yield
- -8.10%
- Share count change, 1 year
- +19.1%
- Share count change, 3-year CAGR
- +30.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- -2.4%
- Average 2-day reaction, last 8
- -0.6%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $14.95
- Target vs current price
- -8.2%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -13.9% | +2.4% | +9.8% | +27.1% | — |
| May 7, 2026 | -26.1% | -1.3% | +5.3% | +99.3% | +117.5% |
| Feb 26, 2026 | +16.1% | +8.7% | +7.5% | -7.3% | -0.7% |
| Nov 4, 2025 | +14.3% | -3.0% | -4.1% | +12.2% | +4.1% |
| Aug 5, 2025 | +8.0% | +1.3% | -19.2% | -13.6% | +75.0% |
| May 6, 2025 | +21.7% | -6.1% | +19.7% | +14.6% | +28.6% |
| Feb 27, 2025 | +28.1% | -5.4% | +0.2% | -23.7% | +3.1% |
| Nov 6, 2024 | -93.9% | -1.1% | -7.3% | -29.3% | -10.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.30 | -$0.26 | -13.9% | $22.4M |
| May 7, 2026 | -$0.29 | -$0.23 | -26.1% | $15.5M |
| Feb 26, 2026 | -$0.26 | -$0.31 | +16.1% | $17.3M |
| Nov 4, 2025 | -$0.24 | -$0.28 | +14.3% | $14.5M |
| Aug 5, 2025 | -$0.23 | -$0.25 | +8.0% | $17.2M |
| May 6, 2025 | -$0.18 | -$0.23 | +21.7% | $20.6M |
| Feb 27, 2025 | -$0.23 | -$0.32 | +28.1% | $16.8M |
| Nov 6, 2024 | -$0.64 | -$0.33 | -93.9% | $25.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 24.14× | — | — | Bottom 18% |
| Free-cash-flow yield | -5.81% | — | — | Bottom 48% |
| Earnings yield | -6.70% | — | — | Top 47% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 96
- Days above the 200-day average
- 94
- 50-day average slope (20 days)
- +6.6%
- 200-day average slope (20 days)
- +7.0%
- Distance from 50-day average
- +5.8%
- Distance from 200-day average
- +54.6%
- RSI (14)
- 52.5
- Relative volume
- 0.55×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 62.6%
- Volatility vs own 5-year history
- 4th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.12
- Correlation with S&P 500
- 0.18
- Current drawdown from 1-year high
- -11.4%
- Maximum drawdown, 3 years
- -55.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 20, 2021 | Oct 23, 2023 | -98.2% | 694 days | Not yet recovered |
| Dec 22, 2020 | Jan 6, 2021 | -25.9% | 9 days | 8 days (Jan 19, 2021) |
| Oct 9, 2020 | Nov 2, 2020 | -19.5% | 16 days | 14 days (Nov 20, 2020) |
| Nov 20, 2020 | Nov 24, 2020 | -18.4% | 2 days | 8 days (Dec 7, 2020) |
| Dec 10, 2020 | Dec 14, 2020 | -11.6% | 2 days | 5 days (Dec 21, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.74B
- EPS, diluted (TTM)
- -$1.09
- Revenue (TTM)
- $69.7M
- 52-week range
- $4.96 – $18.89
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $85.5M | $65.0M | $73.5M | $84.6M | $69.6M |
| Gross profit | $31.7M | $13.3M | $18.2M | $26.8M | $15.8M |
| Operating income | -$65.4M | -$115.5M | -$96.3M | -$68.3M | -$88.1M |
| Net income | -$65.2M | -$113.3M | -$108.3M | -$81.3M | -$81.3M |
| EPS (diluted) | -$1.49 | -$2.48 | -$2.25 | -$1.37 | -$0.91 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.7M | $16.8M | $20.6M | $17.2M | $14.5M | $17.3M | $15.5M | $22.4M |
| Net income | -$39.1M | -$16.4M | -$15.8M | -$20.1M | -$21.7M | -$23.8M | -$30.0M | -$31.7M |
| EPS (diluted) | -$0.64 | -$0.23 | -$0.18 | -$0.23 | -$0.24 | -$0.26 | -$0.29 | -$0.30 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$70.8M | -$70.2M | -$56.3M | -$45.1M | -$74.9M |
| Capital expenditure | -$11.1M | -$49.9M | -$10.9M | -$1.6M | -$4.5M |
| Free cash flow | -$81.9M | -$120.1M | -$67.2M | -$46.8M | -$79.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $162.3M | $2.5M | $3.5M | $97.8M | $129.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $212.7M
- Total assets
- $312.1M
- Total liabilities
- $77.0M
- Total debt
- $38.0M
- Net debt
- -$56.0M
- Shareholders’ equity
- $235.2M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 8,266,193
- Days to cover
- 3.55
- Change vs previous report
- -1.4%
FINRA short interest, settlement date Sep 15, 2026.